Fund Holdings — B Group, Inc.

Total Portfolio Value
$115.78M
Total Bought
$8.81M
Total Sold
$10.59M
Net Transaction
-$1.78M
Filing Period:
Securities
▲▼
SharesValue ($K)
Q1 2025
▲▼
Q2 2025
▲▼
Change
▲▼
Q1 2025
▲▼
Q2 2025
▲▼
Weight (%)
▲▼
Change
▲▼
AKERO THERAPEUTICS INC242,500232,446-10,0549,81612,40310.71%+2,587
TAYSHA GENE THERAPIES INC(TSHA)1,255,5561,800,556+545,0001,7454,1593.59%+2,414
ULTRAGENYX PHARMACEUTICAL IN(RARE)47,500110,000+62,5001,7204,0003.45%+2,280
SIGHT SCIENCES INC(SGHT)833,600930,000+96,4002,0013,8413.32%+1,840
ASSEMBLY BIOSCIENCES INC200,000189,350-10,6501,9123,4312.96%+1,519
CELLECTIS S A(CLLS)3,256,5013,256,50104,0384,9664.29%+928
AURA BIOSCIENCES INC(AURA)472,576572,576+100,0002,7693,5843.10%+815
PRAXIS PRECISION MEDICINES I(PRAX)19,00035,000+16,0007201,4721.27%+752
APOGEE THERAPEUTICS INC(APGE)30,00035,000+5,0001,1211,5201.31%+399
ORUKA THERAPEUTICS INC(ORKA)58,21575,000+16,7855978410.73%+243
SPYRE THERAPEUTICS INC(SYRE)70,00080,000+10,0001,1291,1981.03%+68
ZAI LAB LTD(ZLAB)400,000400,000014,45613,98812.08%-468
89BIO INC95,6230-95,6236950—-695
BIONTECH SE(BNTX)15,0000-15,0001,3660—-1,366
IOVANCE BIOTHERAPEUTICS INC(IOVA)1,500,0001,500,00004,9952,5802.23%-2,415
ADMA BIOLOGICS INC2,317,5422,317,542045,98042,20236.45%-3,778
INSMED INC(INSM)262,500155,000-107,50020,02615,59913.47%-4,427
Page 1 of 1